In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
November 13th, 2014
24.6K views
In this video article, we describe the in vitro synthesis of modified mRNA for induction of protein expression in cells.
Overview
This video article describes the in vitro synthesis of modified mRNA for the induction of protein expression in cells. The procedure involves several key steps, including amplification of the plasmid insert and in vitro transcription.
Key Study Components
Area of Science
- Biotechnology
- Molecular Biology
- Gene Expression
Background
- Modified mRNA can be used to express proteins in cells.
- In vitro synthesis allows for controlled experimentation.
- Understanding mRNA synthesis is crucial for various applications in research.
- This technique can facilitate studies in gene therapy and vaccine development.
Purpose of Study
- To demonstrate the synthesis of modified mRNA.
- To provide a protocol for inducing protein expression in cells.
- To enhance understanding of mRNA applications in research.
Methods Used
- Amplification of plasmid insert or coding DNA sequence.
- Addition of a poly T tail using polymerase chain reaction.
- In vitro transcription of DNA to mRNA with poly A tails.
- Removal of template DNA and five prime phosphates from mRNA.
Main Results
- Successful synthesis of modified mRNA.
- Induction of protein expression in transfected cells.
- Demonstration of effective removal of template DNA.
- Validation of the protocol for future applications.
Conclusions
- The method provides a reliable way to synthesize modified mRNA.
- This approach can be applied in various research fields.
- Further studies can build on this protocol for advanced applications.
Frequently Asked Questions
What is modified mRNA?
Modified mRNA is a form of mRNA that has been chemically altered to enhance stability and translation efficiency in cells.
Why is a poly T tail added?
A poly T tail is added to stabilize the mRNA and facilitate its translation in the cell.
How is template DNA removed?
Template DNA is removed using D'S treatment, which degrades the DNA while leaving the mRNA intact.
What is the role of lipid complexes in this process?
Lipid complexes are used to facilitate the delivery of the synthesized mRNA into cells for protein expression.
Can this method be used for different proteins?
Yes, this method can be adapted to synthesize mRNA for various proteins by changing the plasmid insert.
Executive Industry Relevance
In vitro synthesis of modified mRNA enables rapid, transient protein expression in human cells without genomic integration, supporting early-stage target validation and mechanistic studies. This approach reduces biological risk by avoiding permanent genetic changes and allows for flexible, high-throughput evaluation of protein function. The method is broadly applicable across discovery, screening, and translational research pipelines in biopharma R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of therapeutic hypotheses by transiently expressing candidate proteins in disease-relevant cells.
- Supports functional target validation without risk of genomic integration or oncogenesis.
- Facilitates rapid de-risking of biological mechanisms prior to resource-intensive studies.
Screening & Assay Development
- Provides a standardized workflow for generating validated mRNA for downstream cell-based assays.
- Ensures reproducible, quantitative protein expression for reliable compound screening.
- Allows for scalable preparation of assay-ready cells expressing diverse proteins of interest.
Translational & Preclinical Research
- Enables modeling of protein function in human cells for translational biomarker alignment.
- Supports continuity from discovery through preclinical validation by allowing repeated, controlled protein induction.
- Reduces risk of off-target effects associated with permanent genetic modification.
Pipeline & Workflow Integration
This mRNA synthesis and transfection workflow fits from early discovery through lead identification and preclinical research, enabling iterative hypothesis testing and functional screening.
- Discovery Biology: Supports null hypothesis testing and pathway clarification by enabling controlled protein expression.
- Screening: Delivers reproducible, quantitative outputs for assay development and compound evaluation.
- Analytics: Provides flow cytometry-based measurement of protein expression levels and cell population responses.
- Translational Research: Facilitates alignment with disease models by enabling transient expression of therapeutic proteins.
- Enterprise Reuse: Offers a modular, adaptable platform for diverse protein targets across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes mRNA production and transfection for reproducible, scalable workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling rapid, reversible protein expression studies.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery programs.
Implementation Considerations
- Requires expertise in molecular cloning, in vitro transcription, and cell transfection techniques.
- Needs access to PCR, gel electrophoresis, RNA purification, and flow cytometry instrumentation.
- Demands rigorous quality control of mRNA integrity and purity for reproducible results.
- Must standardize protocols across teams to ensure cross-study comparability.
- Transient expression limits duration of protein function studies to several days post-transfection.
Biopharma FAQs
Why does null hypothesis testing matter for mRNA-induced protein expression?
Null hypothesis testing using transient mRNA expression allows teams to directly assess whether a candidate protein alters cellular phenotypes without confounding genomic integration. This supports robust target validation and reduces mechanistic uncertainty early in the pipeline.
How does independent variable isolation fit the mRNA transfection workflow?
By delivering only the synthetic mRNA of interest, the workflow isolates the effect of the encoded protein as the independent variable, enabling clear attribution of observed cellular responses to the transfected gene product.
What do quantitative flow cytometry measurements enable in this protocol?
Quantitative flow cytometry provides precise measurement of protein expression levels and the proportion of expressing cells, supporting data-driven comparisons across conditions and informing downstream screening or validation decisions.
Why are replication requirements critical for cross-functional mRNA studies?
Replication ensures that observed protein expression and functional outcomes are reproducible across experiments and teams, which is essential for cross-functional collaboration and reliable advancement of discovery programs.
What statistical analysis capabilities are needed before implementing mRNA transfection assays?
Teams must be able to analyze flow cytometry data for expression intensity and cell population shifts, apply appropriate statistical tests, and interpret quantitative outputs to support go/no-go decisions in the discovery pipeline.
Chapters in this video
0:05
Title
1:35
Amplification of Plasmid Inserts and Addition of Poly T-tail by PCR
2:48
In Vitro Transcription
3:59
Treatment of Purified mRNA with Antartic Phosphatase
5:17
mRNA Transfection of Cells
7:01
Flow Cytometric Analyses of eGFP Expression in Cells
8:14
Results: Modified mRNA is Expressed in Human Cells
9:34
Conclusion
